Gadi Levin - 01 Aug 2022 Form 3 Insider Report for BriaCell Therapeutics Corp. (BCTX)

Role
CFO & Secretary
Signature
/s/ Gadi Levin
Issuer symbol
BCTX
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
3
Filing time
01 Aug 2022, 16:10:12 UTC
Previous filing
13 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BCTX Common Shares 2,810 01 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BCTX Option (Right to Buy) 01 Aug 2022 Common Shares 75,000 $4.24 Direct
holding BCTX Option (Right to Buy) 01 Aug 2022 Common Shares 20,000 $4.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option vests quarterly for 2 years from the date of grant.